Previous 10 | Next 10 |
2023-06-23 13:00:34 ET TRxADE HEALTH ( NASDAQ: MEDS ) said on Friday that it had signed a binding letter of intent to acquire Superlatus. After the closing of the deal, Superlatus shareholders will receive 30.8M shares of MEDS, valued at $7.30/share. Other significant...
2023-06-23 10:02:46 ET Gainers: Conformis ( CFMS ) +91% . TRxADE HEALTH ( MEDS ) +11% . Abcam ( ABCM ) +8% . Lexicon Pharmaceuticals ( LXRX ) +4% . Losers: Beyond Air ( XAIR ) -24% . Oramed Pharmaceuticals ( ORMP ) -...
NEW YORK, June 23, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc. (“Superlatus”), a U.S.-based holding company of food products and distribution capabilities , has signed a binding letter of intent (the “LOI”) to be acquired by TRxADE HEALTH, Inc. (NASDAQ:MEDS) (“...
2023-06-22 13:27:35 ET Gainers: TRxADE HEALTH ( MEDS ) +56% . ShiftPixy ( PIXY ) +45% . Root ( ROOT ) +36% . VCI Global Limited ( VCIG ) +34% . Losers: ADS-TEC Energy PLC ( ADSE ) -14% . Polar Power ( POLA ) -12% ...
2023-06-22 13:21:19 ET Gainers: TRxADE HEALTH ( MEDS ) +56% . ShiftPixy ( PIXY ) +45% . Root ( ROOT ) +36% . VCI Global Limited ( VCIG ) +34% . Barfresh Food Group ( BRFH ) +27% . Oncolytics Biotech ( ONCY ) +23% . ...
2023-06-22 10:02:12 ET Gainers: TRxADE HEALTH ( MEDS ) +39% . Talaris Therapeutics ( TALS ) +25% . IGM Biosciences ( IGMS ) +11% . Predictive Oncology ( POAI ) +4% . Zymeworks ( ZYME ) +3% . Losers: Innovative Eyewear...
Lutz, Florida, June 21, 2023 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (Nasdaq: MEDS) (the “Company”), today announced that its board of directors has approved a 1-for-15 reverse stock split of its common stock. The reverse stock split will take effect at 11:59 p.m. Eastern Time on ...
TRxADE Health (NASDAQ: MEDS) , a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is reporting on its financial results for the quarter ended March 31, 2023....
2023-05-15 22:30:09 ET TRxADE HEALTH, Inc. (MEDS) Q1 2023 Earnings Conference Call May 15, 2023 06:00 PM ET Company Participants Prashant Patel - Interim Chief Financial Officer Suren Ajjarapu - Founder, Chairman and Chief Executive Officer Conference Call Part...
2023-05-15 16:25:07 ET Trxade Group press release ( NASDAQ: MEDS ): Q1 GAAP EPS of -$0.03 in-line. Revenue of $2.25M (-30.6% Y/Y) misses by $0.41M . For further details see: Trxade Group GAAP EPS of -$0.03 in-line, revenue of $2.25M misses by $0.41M
News, Short Squeeze, Breakout and More Instantly...
TRxADE (NASDAQ: MEDS) today announced that its board of directors has declared a special cash dividend of $1.50 per share of common stock. According to the announcement, the special dividend is being paid using a portion of the proceeds received in May 2024 in connection with the prior sale of t...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 20.9% to $0.5541 on volume of 173,316,620 shares Assure Holdings Corp. (IONM) rose 114.1% to $0.496799 on volume of 118,668,589 shares NLS Pharmaceutics Ltd. (NLSP) rose 67.6% to $0...
TAMPA, FL, June 27, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH Inc. ( Nasdaq: MEDS ) (the “ Company ”), announced today that with the filing of its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Form 10-Q”), the Company regained complianc...